These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34942276)

  • 1. HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models.
    Assoni G; La Pietra V; Digilio R; Ciani C; Licata NV; Micaelli M; Facen E; Tomaszewska W; Cerofolini L; Pérez-Ràfols A; Varela Rey M; Fragai M; Woodhoo A; Marinelli L; Arosio D; Bonomo I; Provenzani A; Seneci P
    Adv Drug Deliv Rev; 2022 Feb; 181():114088. PubMed ID: 34942276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
    Wu M; Tong CWS; Yan W; To KKW; Cho WCS
    Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
    Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
    Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
    Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
    Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery approaches for HuR-targeted therapy for lung cancer.
    Raguraman R; Shanmugarama S; Mehta M; Elle Peterson J; Zhao YD; Munshi A; Ramesh R
    Adv Drug Deliv Rev; 2022 Jan; 180():114068. PubMed ID: 34822926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.
    Joseph BP; Weber V; Knüpfer L; Giorgetti A; Alfonso-Prieto M; Krauß S; Carloni P; Rossetti G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the multifaceted HuR protein, benefits and caveats.
    Zucal C; D'Agostino V; Loffredo R; Mantelli B; NatthakanThongon ; Lal P; Latorre E; Provenzani A
    Curr Drug Targets; 2015; 16(5):499-515. PubMed ID: 25706256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HuR as a molecular target for cancer therapeutics and immune-related disorders.
    Majumder M; Chakraborty P; Mohan S; Mehrotra S; Palanisamy V
    Adv Drug Deliv Rev; 2022 Sep; 188():114442. PubMed ID: 35817212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
    Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
    Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between HuR and tumor drug resistance.
    Ma Q; Lu Q; Lei X; Zhao J; Sun W; Huang D; Zhu Q; Xu Q
    Clin Transl Oncol; 2023 Jul; 25(7):1999-2014. PubMed ID: 36947360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HuR biological function involves RRM3-mediated dimerization and RNA binding by all three RRMs.
    Pabis M; Popowicz GM; Stehle R; Fernández-Ramos D; Asami S; Warner L; García-Mauriño SM; Schlundt A; Martínez-Chantar ML; Díaz-Moreno I; Sattler M
    Nucleic Acids Res; 2019 Jan; 47(2):1011-1029. PubMed ID: 30418581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomeric transition and dynamics of RNA binding by the HuR RRM1 domain in solution.
    Lixa C; Mujo A; de Magalhães MTQ; Almeida FCL; Lima LMTR; Pinheiro AS
    J Biomol NMR; 2018 Dec; 72(3-4):179-192. PubMed ID: 30535889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturated fatty acids induce post-transcriptional regulation of HAMP mRNA via AU-rich element-binding protein, human antigen R (HuR).
    Lu S; Mott JL; Harrison-Findik DD
    J Biol Chem; 2015 Oct; 290(40):24178-89. PubMed ID: 26304124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
    Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
    ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.
    Moradi F; Berglund P; Linnskog R; Leandersson K; Andersson T; Prasad CP
    Transl Res; 2016 Jun; 172():45-60. PubMed ID: 26970271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
    Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA binding protein HuR regulates extracellular matrix gene expression and pH homeostasis independent of controlling HIF-1α signaling in nucleus pulposus cells.
    Pan H; Strickland A; Madhu V; Johnson ZI; Chand SN; Brody JR; Fertala A; Zheng Z; Shapiro IM; Risbud MV
    Matrix Biol; 2019 Apr; 77():23-40. PubMed ID: 30092282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of HuR in inflammatory response in kidney diseases.
    Shang J; Zhao Z
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):753-763. PubMed ID: 28910975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.
    D'Agostino VG; Lal P; Mantelli B; Tiedje C; Zucal C; Thongon N; Gaestel M; Latorre E; Marinelli L; Seneci P; Amadio M; Provenzani A
    Sci Rep; 2015 Nov; 5():16478. PubMed ID: 26553968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.